Online course aims to give women tools to tame bladder pain
NCT ID NCT07797010
First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time
Summary
Researchers are testing a six-week online program called Learning to THRIVE for women with interstitial cystitis, also known as bladder pain syndrome. The program combines self-paced online lessons with weekly live virtual group meetings to teach pain management, self-care, communication, and informed healthcare decisions. This pilot study enrolls about 15 women and focuses on whether the program is feasible and acceptable, while also exploring its potential to ease symptoms and improve confidence in managing the condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Learning to THRIVE (L2T) Program, a six-week online self-management program with weekly virtual group sessions and self-paced educational materials
- What this could lead to
- If it works, this program could offer a practical, accessible way for women with bladder pain syndrome to better manage symptoms and improve daily life.
- What could go wrong
- This is a small pilot study focused on feasibility, not proof of effectiveness. Results may not generalize, and the program's impact on symptoms remains uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
15 people
The number who actually took part.
- Started
-
Aug 2023
- Finished
-
Dec 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Self-identifies as a woman or female * Age 18 years or older * Self-reported healthcare provider-confirmed diagnosis of interstitial cystitis/bladder pain syndrome (IC/BPS) * Pelvic pain, pressure, or discomfort for at least 6 months, of at least moderate severity (greater than 3 on a 0-10 numerical rating scale), causing weekly life interference and limiting life or work-related activities, general activity level, and/or enjoyment of life during the prior 3 months * Reliable access to a computer and Internet connection Exclusion Criteria: * Unable to speak/read English * Neurological condition (for example, multiple sclerosis, Parkinson disease, paraplegia) or other condition affecting the bladder * History or presence of cystitis caused by tuberculosis, radiation, or chemotherapy * Diagnosed and treated for a pelvic-related malignancy (colon, bladder, ovarian, endometrial, uterine, cervical, vaginal, or rectal cancer) * Physical or psychological comorbidity that would adversely affect ability to participate * Currently pregnant * Gross cognitive impairment, deafness, blindness, or severe vision/hearing problems that could not be accommodated * Current psychotherapy directed specifically toward relief of urological symptoms
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Interstitial cystitis and bladder pain syndrome are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Indianapolis
Indianapolis, Indiana, 46227, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.